Moving beyond the drug budget silo mentality in Europe.
نویسندگان
چکیده
منابع مشابه
Demography and the Coronavirus Pandemic
Abstract. One of the most urgent policy issues related to the COVID-19 pandemic in Europe concerns the extent and ways in which demographics have determined different patterns of mortality between groups and regions, and whether and how the pandemic and its economic consequences will affect population dynamics in the future. Post-pandemic policy evaluations on the spread of COVID-19 and the im...
متن کاملSilo Effect a Prominence Factor to Decrease Efficiency of Pharmaceutical Industry
To be sure, all the industries try to be involved in globalization with a constant trend to find out ways to increase productivity across different functions within an organization to maintain competitive advantage world. Pharmaceutical industries are not exceptional and further are based on fragmentation. So these kind of companies need to cope with several barriers such as silo mentality that...
متن کاملThe drug budget silo mentality in Europe: an overview.
This supplement engages some of the leading health economists in Europe to analyze how the policies in their respective health-care systems to control and influence pharmaceutical spending are likely to influence the overall performance of their systems, with respect to both cost control and the production of population health. Six countries were selected to provide a representative mix of publ...
متن کاملUsing disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany.
OBJECTIVE Germany spends the highest share (10.4%) of its gross domestic product on health care among European Union countries. The majority of this financing comes from an earmarked tax on labor earnings. Drug spending, as a share (12.7%), is relatively low, as is per-capita drug spending. Over the past decade, a number of specific budgeting initiatives were introduced to control drug spending...
متن کاملThe drug budget silo mentality: the Dutch case.
This article provides a broad outline of developments in the Dutch health-care policy related to the costs, budgeting, and reimbursement of pharmaceuticals. In-hospital drugs costs are part of hospital budgets, whereas for the main part of costs, nonhospital drugs, no strict budget exists. The government sets a goal for the annual cost increase of nonhospital drugs, but has only limited means t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
دوره 6 Suppl 1 شماره
صفحات -
تاریخ انتشار 2003